Global Innovative Platforms (GIPL) Net Income towards Common Stockholders (2020 - 2026)
Global Innovative Platforms (GIPL) posted Net Income towards Common Stockholders of -$241,611 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$211,818 a year earlier.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Global Innovative Platforms was -$677,042; for FY2025 (ended Sep 30, 2025), it came in at -$718,251.
- In prior fiscal years, Global Innovative Platforms' Net Income towards Common Stockholders was -$136,197 in FY2024, -$282,786 in FY2023, -$53,816 in FY2022 and -$73,273 in FY2021.
- The fiscal Q3 2026 figure stands as the lowest quarterly Net Income towards Common Stockholders in data going back to fiscal Q1 2021.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior fiscal quarters was -$151,386 (Q2 2026), -$49,429 (Q1 2026) and -$234,616 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Global Innovative Platforms | 24.88 Mn | 24.27 Mn | - | -241,611.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -241,611.00 |
| Mar 31, 2026 | -151,386.00 |
| Dec 31, 2025 | -49,429.00 |
| Sep 30, 2025 | -234,616.00 |
| Jun 30, 2025 | -211,818.00 |
| Mar 31, 2025 | -151,351.00 |
| Dec 31, 2024 | -120,467.00 |
| Sep 30, 2024 | -76,482.00 |
| Jun 30, 2024 | -6,360.00 |
| Mar 31, 2024 | -3,887.00 |
| Dec 31, 2023 | -49,469.00 |
| Sep 30, 2023 | -124,100.00 |
| Jun 30, 2023 | -2,650.00 |
| Mar 31, 2023 | -68,870.00 |
| Dec 31, 2022 | -87,166.00 |
| Sep 30, 2022 | -35,604.00 |
| Jun 30, 2022 | -6,609.00 |
| Mar 31, 2022 | -5,083.00 |
| Dec 31, 2021 | -6,520.00 |
| Sep 30, 2021 | -21,677.00 |
API Access
Global Innovative Platforms Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=GIPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "GIPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=GIPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();